ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
Stereotaxis Inc

Stereotaxis Inc (STXS)

2,35
0,13
(5,86%)
Fermé 22 Décembre 10:00PM
2,3514
0,0014
(0,06%)
Après les heures de négociation: 12:53AM

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Statistiques et détails clés

Dernier
2,3514
Prix Achat
-
Prix Vente
-
Volume échangé
873 952
2,20 Fourchette du Jour 2,36
1,66 Plage de 52 semaines 3,29
Cap du marché
Clôture Veille
2,22
Ouverture
2,20
Dernière Transaction
354280
@
2.35
Dernière heure de transaction
Volume financier
US$ 1 945 428
VWAP
2,226
Volume moyen (3 m)
299 744
Actions en circulation
84 729 507
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-8,87
Bénéfice par action (BPA)
-0,26
Chiffre d'affairess
26,77M
Bénéfice net
-22,06M

À propos de Stereotaxis Inc

Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. The... Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service and accessories stream. The company generates the majority of revenue from the United States. Show more

Secteur
Electromedical Apparatus
Industrie
Medical Eq Rental & Leasing
Siège social
Dover, Delaware, USA
Fondé
2011
Stereotaxis Inc est coté dans le secteur Electromedical Apparatus de la American Stock Exchange avec le ticker STXS. Le dernier cours de clôture d'Stereotaxis était de US$2,22. Au cours de la dernière année, les actions de Stereotaxis ont été négociées dans une fourchette de prix de US$ 1,66 à US$ 3,29.

Stereotaxis compte actuellement 84 729 507 actions en circulation. La capitalisation boursière d'Stereotaxis est de US$188,10 million. Stereotaxis a un ratio cours/bénéfice (ratio PE) de -8.87.

STXS Dernières nouvelles

Magbot Robotic Magnetic Navigation Ablation Catheter Approved by China’s NMPA

ST. LOUIS and SHANGHAI, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS) and Shanghai MicroPort EP Medtech Co., Ltd. (688351.SH, “MicroPort EP”), today announced that the Magbot™...

Stereotaxis’ GenesisX Robotic System to be Showcased for the First Time at RSNA 2024 by Neusoft Medical Systems

ST. LOUIS and SHENYANG, China, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS) and Neusoft Medical Systems Co., Ltd (“Neusoft Medical Systems”) today announced that Stereotaxis’...

Stereotaxis to Participate in Piper Sandler 36th Annual Healthcare Conference

ST. LOUIS, Nov. 26, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that...

Stereotaxis Genesis Robotic System Achieves Regulatory Approval in China

ST. LOUIS and SHANGHAI, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS) and Shanghai MicroPort EP Medtech Co., Ltd. (688351.SH, “MicroPort EP”), today announced regulatory approval of...

Hospital Da Luz is the First in Portugal to Adopt Genesis Robotic System

ST. LOUIS, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that...

Stereotaxis Reports 2024 Third Quarter Financial Results

ST. LOUIS, Nov. 11, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported financial...

University of Kansas Medical Center Enhances Robotic Heart Care Program with Genesis Robotic Technology

ST. LOUIS, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that...

Stereotaxis to Report Third Quarter 2024 Financial Results on November 11, 2024

ST. LOUIS, Oct. 23, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it...

Stereotaxis Technology to be Featured at Annual Meeting of the Society for Cardiac Robotic Navigation

ST. LOUIS, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10.14146.398190045252.212.5052.18014169592.33611443CS
40.301414.70243902442.052.5952.0254171592.27228839CS
120.331416.40594059412.022.5951.822997442.12373647CS
260.501427.10270270271.852.5951.662540002.06347168CS
520.661439.13609467461.693.291.662749962.23991022CS
156-3.3586-58.8196147115.717.221.332633702.33370925CS
260-2.9786-55.88367729835.3310.31.332819643.90019378CS

STXS - Frequently Asked Questions (FAQ)

What is the current Stereotaxis share price?
The current share price of Stereotaxis is US$ 2,3514
How many Stereotaxis shares are in issue?
Stereotaxis has 84 729 507 shares in issue
What is the market cap of Stereotaxis?
The market capitalisation of Stereotaxis is USD 188,1M
What is the 1 year trading range for Stereotaxis share price?
Stereotaxis has traded in the range of US$ 1,66 to US$ 3,29 during the past year
What is the PE ratio of Stereotaxis?
The price to earnings ratio of Stereotaxis is -8,87
What is the cash to sales ratio of Stereotaxis?
The cash to sales ratio of Stereotaxis is 7,31
What is the reporting currency for Stereotaxis?
Stereotaxis reports financial results in USD
What is the latest annual turnover for Stereotaxis?
The latest annual turnover of Stereotaxis is USD 26,77M
What is the latest annual profit for Stereotaxis?
The latest annual profit of Stereotaxis is USD -22,06M
What is the registered address of Stereotaxis?
The registered address for Stereotaxis is 850 NEW BURTON ROAD, SUITE 201, DOVER, DELAWARE, 19904
What is the Stereotaxis website address?
The website address for Stereotaxis is www.stereotaxis.com
Which industry sector does Stereotaxis operate in?
Stereotaxis operates in the MEDICAL EQ RENTAL & LEASING sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
MGLDMarygold Companies Inc
US$ 2,053
(48,77%)
128,45k
MINFT Limited
US$ 7,25
(44,22%)
948,89k
CTMCastellum Inc
US$ 0,578
(41,01%)
8,94M
KULRKULR Technology Group Inc
US$ 2,885
(28,79%)
75,72M
MSTUT Rex 2X Long MSTR Daily Target ETF
US$ 12,49
(22,81%)
64,96M
BATLBattalion Oil Corporation
US$ 1,3499
(-44,56%)
1,63M
NVOXDefiance Daily Target 2x Long Nvo ETF
US$ 11,5991
(-35,47%)
407,1k
UVIX2x Long VIX Futures ETF
US$ 3,83
(-29,07%)
70,61M
TPETTrio Petroleum Corp
US$ 1,10
(-25,17%)
2,81M
MSTZT Rex 2X Inverse MSTR Daily Target ETF
US$ 19,235
(-23,06%)
21,33M
SPYSPDR S&P 500
US$ 591,15
(0,86%)
122,49M
SPXSDirexion Daily S&P 500 Bear 3X Shares New
US$ 6,1628
(-3,25%)
114,87M
SOXLDirexion Daily Semiconductor Bull 3X Shares
US$ 27,30
(3,80%)
108,08M
TSLZT Rex 2X Inverse Tesla Daily Target ETF
US$ 2,435
(7,27%)
94,23M
KULRKULR Technology Group Inc
US$ 2,885
(28,79%)
75,72M
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock